OYAN, B. Et Al. 2005. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9 , 688-697.

OYAN, B., KOC, Y., Ozdemir, E., KARS, A., TURKER, A., TEKUZMAN, G., ... KANSU, E.(2005). Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9, 688-697.

OYAN, B Et Al. "Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation," BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9, 688-697, 2005

OYAN, B Et Al. "Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9, pp.688-697, 2005

OYAN, B. Et Al. (2005) . "Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9, pp.688-697.

@article{article, author={B OYAN Et Al. }, title={Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation}, journal={BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION}, year=2005, pages={688-697} }